|
"tsai m s"的相关文件
显示项目 1-10 / 1376 (共138页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 國立成功大學 |
2023 |
6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
|
Hsu, C.-M.;Su, H.-C.;Yang, M.-Y.;Tsai, Y.-T.;Tsai, M.-S.;Yang, Yang Y.-H.;Wu, C.-Y.;Chang, S.-F. |
| 國立成功大學 |
2023 |
TIMECARD score: An easily operated prediction model of unfavorable neurological outcomes in out-of-hospital cardiac arrest patients with targeted temperature management
|
Lin, J.-J.;Huang, C.-H.;Chien, Y.-S.;Hsu, C.-H.;Chiu, W.-T.;Wu, C.-H.;Wang, C.-H.;Tsai, M.-S. |
| 國立成功大學 |
2023 |
Switching to coformulated bictegravir, emtricitabine, and tenofovir alafenamide maintained viral suppression in adults with historical virological failures and K65N/R mutation
|
Tsai, M.-S.;Sun, H.-Y.;Chen, Chen C.-P.;Lee, C.-H.;Lee, C.-Y.;Liu, C.-E.;Tang, H.-J.;Hung, T.-C.;Li, C.-W.;Lee, Y.-T.;Liou, B.-H.;Yang, C.-J.;Hung, C.-C. |
| 國立成功大學 |
2023 |
Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter Study
|
Sun, H.-Y.;Liou, B.-H.;Chen, T.-C.;Yang, C.-J.;Huang, S.-H.;Lu, P.-L.;Huang, C.-H.;Tsai, M.-S.;Cheng, S.-H.;Lee, N.-Y.;Ko, W.-C.;Chen, Y.-H.;Liu, W.-D.;Lin, S.-Y.;Lin, S.-P.;Chen, P.-L.;Syue, L.-S.;Huang, Y.-S.;Chuang, Y.-C.;Chen, Chen C.-B.;Chang, Y.-T.;Lee, Y.-T.;Hsieh, S.-M.;Su, L.-H.;Cheng, Cheng C.-Y.;Hung, C.-C. |
| 臺大學術典藏 |
2022-09-20T06:48:28Z |
Post-cardiac arrest care and targeted temperature management: A consensus of scientific statement from the Taiwan Society of Emergency & Critical Care Medicine, Taiwan Society of Critical Care Medicine and Taiwan Society of Emergency Medicine
|
Chiu W.-T.; Lin K.-C.; Tsai M.-S.; Hsu C.-H.; Wang C.-H.; Kuo L.-K.; Chien Y.-S.; Wu C.-H.; Lai C.-H.; Huang W.-C.; Wang C.-H.; Wang T.-L.; Hsu H.-H.; Lin J.-J.; HWANG, JUEY-JEN; Ng C.-J.; Choi W.-M.; Huang C.-H. |
| 臺大學術典藏 |
2022-09-07T06:39:26Z |
Therapeutic drug monitoring and pharmacogenetic, study of HIV-infected ethnic chinese receiving efavirenz-containing antiretroviral therapy with or without rifampicin-based anti-tuberculous therapy
|
Lee K.-Y.; SHU-WEN LIN; Sun H.-Y.; Kuo C.-H.; Tsai M.-S.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Chang S.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:25Z |
Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: Incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia
|
Yang J.-J.; Huang C.-H.; Liu C.-E.; Tang H.-J.; Yang C.-J.; Lee Y.-C.; Lee K.-Y.; Tsai M.-S.; SHU-WEN LIN; Chen Y.-H.; Lu P.-L.; Hung C.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:24Z |
Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan
|
Tseng Y.-T.; Yang C.-J.; Chang S.-Y.; SHU-WEN LIN; Tsai M.-S.; Liu W.-C.; Wu P.-Y.; Su Y.-C.; Luo Y.-Z.; Yang S.-P.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:23Z |
Cholelithiasis and nephrolithiasis in HIV-positive patients in the era of combination antiretroviral therapy
|
Lin K.-Y.; Liao S.-H.; Liu W.-C.; Cheng A.; SHU-WEN LIN; Chang S.-Y.; Tsai M.-S.; Kuo C.-H.; Wu M.-R.; Wang H.-P.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2022-09-07T06:39:18Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.; Chang S.-Y.; SHU-WEN LIN; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
显示项目 1-10 / 1376 (共138页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
